Hims & Hers Health stock drops 3.45% as sharp selling follows early gap down

Traders Union
All News
Financial News
Hims & Hers Health drops 3.45% today

Highlights

HIMS trades at $26.33, supported by short- and medium-term technicals but faces significant long-term resistance overhead.
Recent price action reflects strong volatility and seller dominance, with technical signals showing mixed momentum and an overall bearish bias.
Sideways trading is most likely between $25.70 and $26.70 over the coming week, with less than 20% probability of a sustained upside breakout.

Sharply divergent momentum as short-term support meets oversold signals

On the technical side, price action sits at $26.33, just above the MA-20 at $26.07 and well above the MA-50 at $22.52, but remains sharply below the MA-200 at $37.09. The Ichimoku Kijun line on the daily chart is at $25.24 and acts as short-term support. Bullish momentum is present in the daily MACD, while the ADX indicates an established trend without extreme strength. The daily RSI is above 50, showing a general buy signal, but both the Stoch RSI and Bull/Bear Power (BBP) register oversold readings and indicate ongoing seller dominance. Both the Commodity Channel Index and Awesome Oscillator remain neutral, while the session was characterized by a sharp decline after a gap down open and heightened volatility.

Downside bias prevails as upside breakout odds remain subdued

Looking to the next five sessions, price is expected to trade within a typical volatility band between $25.70 and $26.70. Weekly metrics across RSI, ADX, MACD, and MA-50 suggest less than a 20% probability of a sustained upside move, implying further downside risks. The most likely scenario is continued consolidation within this range. A break above $26.70 could open the door for a test of higher resistance levels, while losing $25.70 may trigger a deeper retracement.

Anton Kharitonov, expert at Traders Union, sees Hims & Hers Health Inc trading within a narrow technical range and facing persistent short-term selling pressure. He observes that although daily momentum indicators suggest some buying interest, the sharp drop below long-term averages keeps risk to the downside. Kharitonov remains cautious, citing low chances of a sustained rally and highlighting that further consolidation is likely. "Until $26.70 is reclaimed and defended, I see no strong reason to expect upside — base case is continued range-bound action or deeper pullback if $25.70 fails."

Earlier, analysts noted that Hims & Hers Health was experiencing a consolidative phase, with limited breakout momentum due to mixed technical signals and external pressures. The latest price action and volatility underscore ongoing consolidation, but traders should watch for a confirmed move outside the $25.70 to $26.70 range as a potential catalyst for directional change.

Source of Data: HIMS Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.